BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38489111)

  • 1. Adjuvant treatment for locally advanced gastric cancer: an Asian perspective.
    Kim HD; Ryu MH; Kang YK
    Gastric Cancer; 2024 May; 27(3):439-450. PubMed ID: 38489111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
    Fujitani K
    Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
    Kang YK; Yook JH; Park YK; Lee JS; Kim YW; Kim JY; Ryu MH; Rha SY; Chung IJ; Kim IH; Oh SC; Park YS; Son T; Jung MR; Heo MH; Kim HK; Park C; Yoo CH; Choi JH; Zang DY; Jang YJ; Sul JY; Kim JG; Kim BS; Beom SH; Cho SH; Ryu SW; Kook MC; Ryoo BY; Kim HK; Yoo MW; Lee NS; Lee SH; Kim G; Lee Y; Lee JH; Noh SH
    J Clin Oncol; 2021 Sep; 39(26):2903-2913. PubMed ID: 34133211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status and prospect of perioperative therapy for locally advanced gastric cancer].
    Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):101-106. PubMed ID: 33508913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives.
    Tokunaga M; Sato Y; Nakagawa M; Aburatani T; Matsuyama T; Nakajima Y; Kinugasa Y
    Surg Today; 2020 Jan; 50(1):30-37. PubMed ID: 31612329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy in locally advanced gastric cancer: what to avoid. Preliminary analysis of a consecutive series of patients.
    Rausei S; Lianos GD; Proserpio I; Ruspi L; Galli F; Frattini F; Mangano A; Rovera F; Boni L; Roukos DH; Pinotti G; Dionigi G
    Tumori; 2015; 101(5):511-6. PubMed ID: 25908036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
    Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
    BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study.
    Su P; Jiang L; Zhang Y; Yu T; Huang H; Chen M; Cao C; Kang W; Liu Y; Yu J
    Eur J Med Res; 2023 Oct; 28(1):409. PubMed ID: 37814327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thinking of the application of membrane anatomy in gastric cancer surgery after neoadjuvant therapy].
    Zhao DB; Zhang XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(7):657-660. PubMed ID: 32683826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients.
    Ota M; Saeki H; Uehara H; Matsuda Y; Tsutsumi S; Kusumoto T; Yasui H; Ubukata Y; Yamaguchi S; Orita H; Izawa N; Kakizoe S; Shimokawa M; Yoshizumi T; Kakeji Y; Mori M; Oki E
    Int J Clin Oncol; 2023 Sep; 28(9):1166-1175. PubMed ID: 37368093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chinese expert consensus on perioperative treatment of locally advanced gastric cancer (2021 version)].
    Gastric Cancer Association, China Anti-Cancer Association
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):741-748. PubMed ID: 34530553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
    Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
    World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvant therapy for locally advanced gastric cancer.
    Aoyama T; Yoshikawa T
    Surg Today; 2017 Nov; 47(11):1295-1302. PubMed ID: 28251375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 18. Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Where we Stand; An Italian Single Center Perspective.
    Marino E; Graziosi L; Donini A
    In Vivo; 2021; 35(6):3459-3466. PubMed ID: 34697182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
    Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
    BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer.
    Morant R
    Onkologie; 2001 Apr; 24(2):116-21. PubMed ID: 11441289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.